Future Pharmacology is a peer-reviewed english-language open-access journal published by MDPI AG in Switzerland, operating under an open-access model since 2021. The journal covers Therapeutics. Pharmacology.
Authors are required to pay an article processing charge to publish in Future Pharmacology; refer to the journal's APC page for the current rate. A waiver policy is offered for eligible authors. Articles are released under the CC BY, Publisher's own license license (see other journals using this license).
To date, Future Pharmacology has published 254 articles. Articles are minted with DOIs through the prefix 10.3390. All submissions undergo plagiarism screening before peer review.
Keywords
drug design and discovery, clinical pharmacology, cellular pharmacology, neuropharmacology, drug misuse and addiction, biopharmaceuticals
At a glance
- Publisher
- MDPI AG
- Country
- Switzerland
- Primary language
- English
- License
- CC BY, Publisher's own license
- Peer review
- Anonymous peer review
- OA since
- 2021
- Review time
- 6 weeks
- DOI prefix
10.3390- Plagiarism check
- Yes
ISSN
- electronic
- 2673-9879
Frequently asked questions
Is Future Pharmacology peer-reviewed?
Does Future Pharmacology charge an article processing charge (APC)?
What subjects does Future Pharmacology publish?
What languages does Future Pharmacology accept?
What is the ISSN of Future Pharmacology?
2673-9879 (electronic).